Somaxon Pharmaceuticals Inc. has a market cap of $129.3 million; its shares were traded at around $2.87 with and P/S ratio of 93.4.
This is the annual revenues and earnings per share of SOMX over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of SOMX.
CEO Recent Trades:
- Sell: President and CEO Richard W Pascoe sold 13,781 shares of SOMX stock on 12/01/2010 at the average price of 2.68. Richard W Pascoe owns at least 71,709 shares after this. The price of the stock has increased by 7.09% since.
This is the insider trade history vs. stock price of SOMX. For the complete insider trading history of SOMX, click here.
Directors and Officers Recent Trades:
- Sell: Director Erle T Mast sold 5,000 shares of SOMX stock on 04/01/2011 at the average price of 2.81. Erle T Mast owns at least 41,630 shares after this. The price of the stock has increased by 2.14% since.
- Sell: Director Erle T Mast sold 10,000 shares of SOMX stock on 02/15/2011 at the average price of 3.01. Erle T Mast owns at least 46,630 shares after this. The price of the stock has decreased by 4.65% since.
- Sell: SVP, Chief Commercial Officer Jeffrey Raser sold 16,115 shares of SOMX stock on 01/06/2011 at the average price of 3.5. Jeffrey Raser owns at least 26,667 shares after this. The price of the stock has decreased by 18% since.
- Sell: Director Erle T Mast sold 10,000 shares of SOMX stock on 01/03/2011 at the average price of 3.23. Erle T Mast owns at least 56,630 shares after this. The price of the stock has decreased by 11.15% since.
- Sell: Director Kurt Von Emster sold 26,000 shares of SOMX stock on 12/02/2010 at the average price of 2.78. Kurt Von Emster owns at least 27,079 shares after this. The price of the stock has increased by 3.24% since.
For the complete insider trading history of SOMX, click here.






RSS